TG Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1994
Net Income	12.67	-198.34	-348.1	-279.38	-172.87	-173.48	-118.48	-78.25	-62.95	-55.78	Upgrade
Depreciation & Amortization	0.21	0.3	0.28	0.16	0.1	0.09	0.08	0.06	0.02	0	Upgrade
Share-Based Compensation	37.93	19.19	61.27	80.29	11.34	12.89	15.95	7.51	15.7	21.11	Upgrade
Other Operating Activities	-82.23	2.68	-9.09	-15.57	28.63	31.58	8.69	9.09	2.55	-0.39	Upgrade
Operating Cash Flow	-31.41	-176.17	-295.63	-214.51	-132.81	-128.93	-93.76	-61.59	-44.69	-35.06	Upgrade
Capital Expenditures	0	-0.01	-0.4	-0.36	-0.13	-0.09	-0	-0.34	-0.04	-0.02	Upgrade
Change in Investments	-50.65	-20	0.07	-24.15	-0.59	1.27	-8.21	26.89	-24.64	-18.34	Upgrade
Investing Cash Flow	-50.65	-20.01	-0.33	-24.51	-0.72	1.18	-8.21	26.55	-24.69	-18.36	Upgrade
Share Issuance / Repurchase	47.83	0.58	2.44	679.83	175.02	113.64	133.66	5.03	68.83	69.37	Upgrade
Debt Issued / Paid	25	-0.98	40	0	29.99	0	0	0	0	-0.68	Upgrade
Other Financing Activities	-0.13	-	-1.02	-	-0.8	-	-	-0.01	-0.1	-0.05	Upgrade
Financing Cash Flow	72.71	-0.39	41.42	679.83	204.21	113.64	133.66	5.02	68.72	68.64	Upgrade
Net Cash Flow	-9.36	-196.57	-254.55	440.81	70.69	-14.11	31.69	-30.03	-0.65	15.23	Upgrade
Free Cash Flow	-31.41	-176.18	-296.04	-214.86	-132.94	-129.02	-93.76	-61.93	-44.73	-35.08	Upgrade
Free Cash Flow Margin	-13.44%	-6326.18%	-4425.70%	-141357.89%	-87458.55%	-84878.29%	-61685.53%	-40744.08%	-29429.27%	-23077.95%	Upgrade
Free Cash Flow Per Share	-0.22	-1.30	-2.24	-1.86	-1.50	-1.71	-1.51	-1.13	-0.98	-1.03	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).